These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36456394)

  • 1. SOHO State of the Art Updates and Next Questions |The Role of Maintenance Therapy in Acute Myeloid Leukemia.
    Babakhanlou R; Ravandi-Kashani F
    Clin Lymphoma Myeloma Leuk; 2023 Jan; 23(1):1-7. PubMed ID: 36456394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach.
    Kantarjian HM; Kadia TM; DiNardo CD; Welch MA; Ravandi F
    Cancer; 2021 Apr; 127(8):1186-1207. PubMed ID: 33734442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML and the art of remission maintenance.
    de Lima M; Roboz GJ; Platzbecker U; Craddock C; Ossenkoppele G
    Blood Rev; 2021 Sep; 49():100829. PubMed ID: 33832807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance therapy in acute myeloid leukemia: What is the future?
    McMahon CM; Luger SM
    Semin Hematol; 2019 Apr; 56(2):102-109. PubMed ID: 30926085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation from acute promyelocytic leukemia to acute myeloid leukemia with a CEBPA double mutation: A case report and review of the literature.
    Sun Y; Wang C; Sun Y; Wang J; Rong C; Wu A; Ouyang G; Sheng L
    Medicine (Baltimore); 2021 Feb; 100(5):e24385. PubMed ID: 33592885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance therapy in AML: The past, the present and the future.
    Molica M; Breccia M; Foa R; Jabbour E; Kadia TM
    Am J Hematol; 2019 Nov; 94(11):1254-1265. PubMed ID: 31429099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conventional chemotherapy for acute myeloid leukemia: a Brazilian experience.
    Pagnano KB; Traina F; Takahashi T; Oliveira GB; Rossini MS; Lorand-Metze I; Vigorito AC; Miranda EC; De Souza CA
    Sao Paulo Med J; 2000 Nov; 118(6):173-8. PubMed ID: 11120548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.
    Zheng WS; Hu YL; Guan LX; Peng B; Wang SY
    Hematology; 2021 Dec; 26(1):179-185. PubMed ID: 33594943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted and cytotoxic therapies as maintenance treatment for non-transplant eligible patients with acute myeloid leukemia.
    Patel SA; Litzow MR; Cerny J
    Blood Rev; 2021 Nov; 50():100863. PubMed ID: 34210571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-2 as maintenance therapy for children and adults with acute myeloid leukaemia in first complete remission.
    Mao C; Fu XH; Yuan JQ; Yang ZY; Huang YF; Ye QL; Wu XY; Hu XF; Zhai ZM; Tang JL
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010248. PubMed ID: 26544114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem.
    Latagliata R; Petti MC; Fenu S; Mancini M; Spiriti MA; Breccia M; Brunetti GA; Avvisati G; Lo Coco F; Mandelli F
    Blood; 2002 Feb; 99(3):822-4. PubMed ID: 11806982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylating agents as maintenance therapy following allogeneic hematopoietic cell transplantation for myeloid malignancies.
    Appelbaum FR
    Best Pract Res Clin Haematol; 2021 Mar; 34(1):101241. PubMed ID: 33762112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid Leukemia.
    Tedjaseputra A; Russell N; Dillon R
    Clin Lymphoma Myeloma Leuk; 2024 Mar; ():. PubMed ID: 38734498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance Therapy in AML.
    Reville PK; Kadia TM
    Front Oncol; 2020; 10():619085. PubMed ID: 33604298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
    Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
    Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maintenance therapy for acute myeloid leukemia (including in patients who have undergone transplantation) including off-label use drugs in Japan].
    Kiguchi T
    Rinsho Ketsueki; 2021; 62(8):978-987. PubMed ID: 34497238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for patients with acute myeloid leukemia in first remission.
    Bradstock K
    Curr Hematol Malig Rep; 2006 Jun; 1(2):108-13. PubMed ID: 20425340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOHO State of the Art Updates and Next Questions: Oral Therapy in Acute Myeloid Leukemia.
    Nasnas P; Ravandi F
    Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):205-213. PubMed ID: 38114391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult acute leukemia.
    Cripe LD
    Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.